85 related articles for article (PubMed ID: 24573767)
21. Basal Ki67 expression measured by digital image analysis is optimal for prognostication in oral squamous cell carcinoma.
Klimowicz AC; Bose P; Nakoneshny SC; Dean M; Huang L; Chandarana S; Magliocco AM; Wayne Matthews T; Brockton NT; Dort JC
Eur J Cancer; 2012 Sep; 48(14):2166-74. PubMed ID: 22892062
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of CXCR-4 expression in oral squamous cell carcinoma.
Lee JI; Jin BH; Kim MA; Yoon HJ; Hong SP; Hong SD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 May; 107(5):678-84. PubMed ID: 19272813
[TBL] [Abstract][Full Text] [Related]
23. What real influence does the proto-oncogene c-myc have in OSCC behavior?
Pérez-Sayáns M; Suárez-Peñaranda JM; Pilar GD; Barros-Angueira F; Gándara-Rey JM; García-García A
Oral Oncol; 2011 Aug; 47(8):688-92. PubMed ID: 21708481
[TBL] [Abstract][Full Text] [Related]
24. Expression of RCAS1 is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan.
Tsai TC; Yu CH; Cheng SJ; Liu BY; Chen HM; Chiang CP
Oral Oncol; 2008 Aug; 44(8):759-66. PubMed ID: 18061525
[TBL] [Abstract][Full Text] [Related]
25. Four-protein signature accurately predicts lymph node metastasis and survival in oral squamous cell carcinoma.
Zanaruddin SN; Saleh A; Yang YH; Hamid S; Mustafa WM; Khairul Bariah AA; Zain RB; Lau SH; Cheong SC
Hum Pathol; 2013 Mar; 44(3):417-26. PubMed ID: 23026198
[TBL] [Abstract][Full Text] [Related]
26. MUC4 and ErbB2 expression in squamous cell carcinoma of the upper aerodigestive tract: correlation with clinical outcomes.
Weed DT; Gomez-Fernandez C; Yasin M; Hamilton-Nelson K; Rodriguez M; Zhang J; Carraway KL
Laryngoscope; 2004 Aug; 114(8 Pt 2 Suppl 101):1-32. PubMed ID: 15284539
[TBL] [Abstract][Full Text] [Related]
27. Expression of alpha-dystroglycan correlates with tumour grade and predicts survival in oral squamous cell carcinoma.
Sgambato A; Caredda E; Leocata P; Rossi G; Boninsegna A; Vitale A; Grandi T; Cittadini A; Migaldi M
Pathology; 2010 Apr; 42(3):248-54. PubMed ID: 20350218
[TBL] [Abstract][Full Text] [Related]
28. FAS ligand expression in inflammatory infiltrate lymphoid cells as a prognostic marker in oral squamous cell carcinoma.
Peterle GT; Santos M; Mendes SO; Carvalho-Neto PB; Maia LL; Stur E; Agostini LP; Silva CV; Trivilin LO; Nunes FD; Carvalho MB; Tajara EH; Louro ID; Silva-Conforti AM
Genet Mol Res; 2015 Sep; 14(3):11145-53. PubMed ID: 26400345
[TBL] [Abstract][Full Text] [Related]
29. Expression and prognostic impact of indoleamine 2,3-dioxygenase in oral squamous cell carcinomas.
Laimer K; Troester B; Kloss F; Schafer G; Obrist P; Perathoner A; Laimer J; Brandacher G; Rasse M; Margreiter R; Amberger A
Oral Oncol; 2011 May; 47(5):352-7. PubMed ID: 21440489
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of activated Akt expression in oral squamous cell carcinoma.
Lim J; Kim JH; Paeng JY; Kim MJ; Hong SD; Lee JI; Hong SP
J Clin Pathol; 2005 Nov; 58(11):1199-205. PubMed ID: 16254112
[TBL] [Abstract][Full Text] [Related]
31. Apoptosis-associated markers and clinical outcome in human oral squamous cell carcinomas.
Kato K; Kawashiri S; Yoshizawa K; Kitahara H; Yamamoto E
J Oral Pathol Med; 2008 Jul; 37(6):364-71. PubMed ID: 18410312
[TBL] [Abstract][Full Text] [Related]
32. Clinical significance of apoptosis-associated speck-like protein containing a caspase recruitment domain in oral squamous cell carcinoma.
Shimane T; Kobayashi H; Takeoka M; Kitazawa M; Matsumura T; Hida S; Xiao T; Koike T; Taniguchi S; Kurita H
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Jun; 115(6):799-809. PubMed ID: 23706920
[TBL] [Abstract][Full Text] [Related]
33. Expression of Gα12 predicts progression and prognosis of oral squamous cell carcinomas in Taiwan.
Cheng SJ; Liu YC; Cheng SL; Lee JJ; Chen HM; Chang HH; Kok SH; Kuo MY; Chiang CP
J Oral Pathol Med; 2013 Aug; 42(7):565-9. PubMed ID: 23438080
[TBL] [Abstract][Full Text] [Related]
34. Expression of urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor and maspin in oral squamous cell carcinoma: Association with mode of invasion and clinicopathological factors.
Yoshizawa K; Nozaki S; Kitahara H; Kato K; Noguchi N; Kawashiri S; Yamamoto E
Oncol Rep; 2011 Dec; 26(6):1555-60. PubMed ID: 21833477
[TBL] [Abstract][Full Text] [Related]
35. Clinical and histopathologic parameters in survival of oral squamous cell carcinoma.
Dissanayaka WL; Pitiyage G; Kumarasiri PV; Liyanage RL; Dias KD; Tilakaratne WM
Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Apr; 113(4):518-25. PubMed ID: 22668430
[TBL] [Abstract][Full Text] [Related]
36. Significant association of SRC protein expression with the progression, recurrence, and prognosis of oral squamous cell carcinoma in Taiwan.
Cheng SJ; Kok SH; Lee JJ; Yen-Ping Kuo M; Cheng SL; Huang YL; Chen HM; Chang HH; Chiang CP
Head Neck; 2012 Sep; 34(9):1340-5. PubMed ID: 22052839
[TBL] [Abstract][Full Text] [Related]
37. Coexpression of hypoxia-inducible factor-1α and glucose transporter-1 is associated with poor prognosis in oral squamous cell carcinoma patients.
Eckert AW; Lautner MH; Schütze A; Taubert H; Schubert J; Bilkenroth U
Histopathology; 2011 Jun; 58(7):1136-47. PubMed ID: 21438910
[TBL] [Abstract][Full Text] [Related]
38. The significance of p53 immunoexpression with different clones (DO-7 and PAb-240) in oral squamous cell carcinoma.
Silva Júnior Jde A; Camisasca DR; Bernardo V; Ribeiro GS; Dias FL; de Faria PA; de Amorim LM; Lourenço SQ
ORL J Otorhinolaryngol Relat Spec; 2013; 75(2):82-90. PubMed ID: 23817043
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of molecular markers in oral squamous cell carcinoma: a multivariate analysis.
Shah NG; Trivedi TI; Tankshali RA; Goswami JV; Jetly DH; Shukla SN; Shah PM; Verma RJ
Head Neck; 2009 Dec; 31(12):1544-56. PubMed ID: 19424974
[TBL] [Abstract][Full Text] [Related]
40. Tumor lymphangiogenesis correlates with lymph node metastasis and clinicopathologic parameters in oral squamous cell carcinoma.
Miyahara M; Tanuma J; Sugihara K; Semba I
Cancer; 2007 Sep; 110(6):1287-94. PubMed ID: 17674352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]